Analyst firms · Guggenheim · TDOC

Guggenheim TDOC price target and rating history

Teladoc Health Inc. (TDOC) · Health Care

Guggenheim rates Teladoc Health Inc. (TDOC) Neutral with a $25 price target, as of its latest action on Oct 24, 2022. It has published 4 rating actions on TDOC since April 2022, including 1 upgrade and 2 downgrades. Across 3 firms with a TDOC price target in the last 12 months, the median target is $8.50.

Current rating
Neutral
Price target
$25
Median target, all firms
$8.50
Actions on TDOC
4

Guggenheim price target on TDOC

$96$61$252023202420252026
Guggenheim price target on TDOC, each point a stated target, April 2022 to August 2022.

Every Guggenheim rating on TDOC

How other firms rate TDOC

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Argus ResearchSellNov 2, 2026
Deutsche BankBuy$11Mar 10, 2026
BofA SecuritiesBuy$7Feb 26, 2026
BarclaysEqual Weight$8.50Dec 9, 2025

Questions about Guggenheim and TDOC

What is Guggenheim's price target for TDOC?
Guggenheim's latest stated price target for Teladoc Health Inc. (TDOC) is $25, from its action on Aug 17, 2022.
What is Guggenheim's rating on TDOC?
Guggenheim rates TDOC Neutral, a neutral rating, as of Oct 24, 2022.
When did Guggenheim last change its view on TDOC?
On Oct 24, 2022, Guggenheim upgrades to Neutral from Sell.
How does Guggenheim's TDOC target compare with other analysts?
Across 3 firms with a TDOC price target in the last 12 months, the median target is $8.50.

More TDOC rating histories

All Guggenheim ratingsTDOC news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.